French State Opposes Sale of Biogaran by Servier

The French state has instructed drugmaker Servier that it opposes any sale of its generics subsidiary, Biogaran. This entity holds nearly a third of the French market share. Reports last month indicated that Servier had invited potential buyers to submit their offers by mid-June.

The French state has told drugmaker Servier it was against any sale of its generics subsidiary Biogaran, which has a market share of almost a third in France, French Prime Ministers Gabriel Attal told lawmakers on Wednesday.

French media reported last month that Servier had asked potential suitors to file their offers by mid-June.